Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL-1.

Authors	Klaus F Rabe, Ian D Pavord, Mario Castro, Michael E Wechsler, Nadia Daizadeh, Upender Kapoor, Benjamin Ortiz, Amr Radwan, Robert R Johnson, Paul J Rowe, Yamo Deniz, Juby A Jacob-Nara
Journal	The European respiratory journal (Eur Respir J) Vol. 59 Issue 6 (06 2022) ISSN: 1399-3003 [Electronic] England
PMID	35487538 (Publication Type: Letter)
Chemical References	Anti-Asthmatic Agents Antibodies, Monoclonal, Humanized dupilumab
Topics	Anti-Asthmatic Agents (therapeutic use) Antibodies, Monoclonal, Humanized (therapeutic use) Asthma (drug therapy) Eosinophils Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!